AI Assistant
Blog
Pricing
Log In
Sign Up
Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein–Barr virus
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
